FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Paradigm Medical Industries, Inc. Stock AnalysisComprehensive stock analysis for Paradigm Medical Industries, Inc. (PDMI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPDMI
PDMI
Paradigm Medical Industries, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PDMI
Home🔹Stocks🔹Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc.

PDMI•OTC

Paradigm Medical Industries, Inc.

PDMI•OTC
Market cap
$324.88K
Sentiment

Your view on PDMI

Mkt Cap
$324.88K
Sentiment
Your view
PDMI
Paradigm Medical Industries, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PDMI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Paradigm Medical Industries, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Charles S. Pritchard
Headquarters
4273 South 590 West, Salt Lake City, UT, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Charles S. Pritchard
Headquarters
4273 South 590 West, Salt Lake City, UT, US
Description

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News